Authors
No takes yet. Share an insight, caveat, or question.
Randomized trial demonstrates decreased angiogenesis in neuroendocrine tumors, indicating therapeutic potential for IFN-alpha.
Marschall et al. (2003) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: